4.6 Editorial Material

Does Metformin Interfere With the Cardiovascular Benefits of SGLT2 Inhibitors? Questions About Its Role as the Cornerstone of Diabetes Treatment

Journal

AMERICAN JOURNAL OF MEDICINE
Volume 133, Issue 7, Pages 781-782

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2020.01.016

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available